| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |